We are live on ! Find out more
GCM

Glenview Capital Management Portfolio holdings

AUM $3.98B
1-Year Est. Return 20.52%
This Fund
S&P 500
This Quarter Est. Return
-13.27%
1 Year Est. Return
+20.52%
3 Year Est. Return
+68.18%
5 Year Est. Return
+87.14%
10 Year Est. Return
+400.35%
AUM
$4B
AUM Growth
-$942M
Cap. Flow
-$186M
Cap. Flow %
-4.65%
Top 10 Hldgs %
60.38%
Holding
66
New
6
Increased
24
Reduced
16
Closed
11

Top Buys

Rank Stock Value
1
CI icon
Cigna
CI
+$124M
2
MSFT icon
Microsoft
MSFT
+$55.7M
3
FMC icon
FMC
FMC
+$49.1M
4
CHNG
Change Healthcare Inc. Common Stock
CHNG
+$40.7M
5
APTV icon
Aptiv
APTV
+$39.8M

Top Sells

Rank Stock Value
1
BHC icon
Bausch Health
BHC
+$212M
2
MTOR
MERITOR, Inc.
MTOR
+$126M
3
COR icon
Cencora
COR
+$116M
4
UHS icon
Universal Health Services
UHS
+$89.7M
5
MCK icon
McKesson
MCK
+$67.3M

Sector Composition

Rank Sector Weight
1 Healthcare 42.56%
2 Technology 19.65%
3 Industrials 9.92%
4 Materials 8.09%
5 Consumer Staples 7.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
URI icon
26
United Rentals
URI
$69.5B
$48.6M 1.22%
200,163
+83,733
+72% +$24.6M
BKD icon
27
Brookdale Senior Living
BKD
$3.43B
$44.7M 1.12%
9,844,673
-2,741,607
-22% -$16.2M
BSX icon
28
Boston Scientific
BSX
$72B
$33.4M 0.83%
895,396
-489,233
-35% -$19.9M
CLVT icon
29
Clarivate
CLVT
$1.24B
$33.1M 0.83%
+2,390,852
New +$35.8M
MYGN icon
30
Myriad Genetics
MYGN
$285M
$30.8M 0.77%
1,696,791
-40,218
-2% -$835K
LVS icon
31
Las Vegas Sands
LVS
$30.6B
$25.3M 0.63%
754,104
-267,426
-26% -$9.25M
WTW icon
32
Willis Towers Watson
WTW
$31.7B
$25.2M 0.63%
+127,721
New +$27.4M
HOLX
33
DELISTED
Hologic
HOLX
$24.9M 0.62%
359,381
ATVI
34
DELISTED
Activision Blizzard
ATVI
$24.1M 0.6%
309,132
GOOGL icon
35
Alphabet (Google) Class A
GOOGL
$4.57T
$23.6M 0.59%
216,700
+46,140
+27% +$5.43M
KNX icon
36
Knight Transportation
KNX
$11.1B
$22.9M 0.57%
+495,100
New +$23.4M
SABR icon
37
Sabre
SABR
$779M
$17.4M 0.44%
2,983,469
-150,600
-5% -$1.26M
BFLY icon
38
Butterfly Network
BFLY
$2.19B
$16.8M 0.42%
5,464,751
META icon
39
Meta Platforms (Facebook)
META
$1.5T
$14.2M 0.36%
88,230
+9,690
+12% +$1.87M
MRTX
40
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$13.7M 0.34%
203,800
+87,690
+76% +$5.58M
QSI icon
41
Quantum-Si Incorporated
QSI
$162M
$12.2M 0.3%
5,250,000
-528,299
-9% -$2.02M
CELL
42
DELISTED
PhenomeX Inc. Common Stock
CELL
$11.6M 0.29%
2,325,567
+1,132,235
+95% +$5.93M
CHNG
43
CALL
DELISTED
Change Healthcare Inc. Common Stock
CHNG
$11.5M 0.29%
500,000
EPAM icon
44
EPAM Systems
EPAM
$5.6B
$11.3M 0.28%
+38,500
New +$11.8M
BKNG icon
45
Booking.com
BKNG
$149B
$10.5M 0.26%
150,400
-3,675
-2% -$314K
GTM
46
ZoomInfo Technologies
GTM
$1.05B
$10.2M 0.26%
+308,154
New +$13.6M
IS
47
DELISTED
ironSource Ltd.
IS
$8.36M 0.21%
3,510,748
-3,499,667
-50% -$11.7M
EVLV icon
48
Evolv Technologies
EVLV
$1.02B
$7.98M 0.2%
2,999,461
+1,500,000
+100% +$3.99M
DMRC icon
49
Digimarc Corp
DMRC
$161M
$7.78M 0.19%
550,000
+475,000
+633% +$9.8M
CTKB icon
50
Cytek Biosciences
CTKB
$557M
$5.37M 0.13%
500,000
+444,587
+802% +$4.43M

Similar funds

Glenview Capital Management's Q2 2022 Portfolio in Review

As of Q2 2022, Glenview Capital Management held 66 positions worth $4B, down 19% from $4.94B the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Glenview Capital Management withdrew a net $186M in Q2 2022, closing 11 positions and reducing 16 holdings. Its most notable exit was Bausch Health, an estimated $212M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 43% of assets, down from 49% a quarter earlier, followed by Technology and Industrials.

Against the trend, Glenview Capital Management opened a new position in Microsoft worth $52.8M.

  • Glenview Capital Management's largest Q2 2022 buy was Microsoft: 205,392 shares worth $52.8M.
  • Glenview Capital Management added most to Cigna in Q2 2022, an estimated $124M increase.
  • Glenview Capital Management's biggest Q2 2022 reduction was McKesson, cutting an estimated $67.3M.
  • Glenview Capital Management fully exited Bausch Health in Q2 2022, selling an estimated $212M.
  • Glenview Capital Management's ten largest holdings make up 60% of its $4B portfolio in Q2 2022.
  • Glenview Capital Management opened 6 new positions and closed 11 in Q2 2022.
  • Glenview Capital Management's portfolio value fell 19% quarter-over-quarter to $4B.

Based on Glenview Capital Management's 13F filing for Q2 2022, filed 11 Aug 2022.